Endometrial carcinoma in a breast cancer patient treated with tamoxifen

  • Authors:
    • M Varras
    • G Zachos
    • D Spandidos
  • View Affiliations

  • Published online on: September 1, 1997     https://doi.org/10.3892/or.4.5.1045
  • Pages: 1045-1046
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The use of tamoxifen for breast cancer therapy is linked to an increased danger of developing endometrial neoplasias in postmenopausal patients receiving the drug. Understanding the molecular mechanisms of the tumorigenic activity of tamoxifen may be of great prognostic and therapeutic significance. Our study suggests that tamoxifen treatment and alterations of the K-ras proto-oncogene may occur as parallel events in carcinogenesis of the endometrium.

Related Articles

Journal Cover

September 1997
Volume 4 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Varras M, Zachos G and Spandidos D: Endometrial carcinoma in a breast cancer patient treated with tamoxifen. Oncol Rep 4: 1045-1046, 1997
APA
Varras, M., Zachos, G., & Spandidos, D. (1997). Endometrial carcinoma in a breast cancer patient treated with tamoxifen. Oncology Reports, 4, 1045-1046. https://doi.org/10.3892/or.4.5.1045
MLA
Varras, M., Zachos, G., Spandidos, D."Endometrial carcinoma in a breast cancer patient treated with tamoxifen". Oncology Reports 4.5 (1997): 1045-1046.
Chicago
Varras, M., Zachos, G., Spandidos, D."Endometrial carcinoma in a breast cancer patient treated with tamoxifen". Oncology Reports 4, no. 5 (1997): 1045-1046. https://doi.org/10.3892/or.4.5.1045